lifestyle.celebhomes.net
Home
Sample Page
Author:
Inovio Pharmaceuticals, Inc.
INOVIO to Report First Quarter Financial Results on May 13, 2026
May 1, 2026
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
INOVIO Announces Proposed Public Offering
April 1, 2026
INOVIO to Participate in Upcoming Scientific Conference
April 1, 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 12, 2026
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
December 29, 2025
INOVIO Reports Inducement Grant Under Inducement Plan
December 21, 2025